News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Edward Cliff: The development and clinical trial design of T-cell lymphoma drugs pralatrexate and belinostat
Photo of Edward Cliff from hmpgloballearningnetwork.com
Jul 27, 2024, 14:57

Edward Cliff: The development and clinical trial design of T-cell lymphoma drugs pralatrexate and belinostat

Edward Cliff, Haematology Registrar at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, shared a post on X about a recent paper titled “US Food and Drug Administration’s Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma” published in Journal of Clinical Oncology.

Authors: Edward R. Scheffer Cliff, David A. Russler-Germain, C. Joseph Ross Daval and Aaron S. Kesselheim.

Edward Cliff: The development and clinical trial design of T-cell lymphoma drugs pralatrexate and belinostat

“In Journal of Clinical Oncology we review the development and clinical trial design of T-cell lymphoma drugs pralatrexate and belinostat, and discuss strategies for FDA Oncology to deal with delayed confirmatory clinical trials.

Read here.”

Source: Edward Cliff/X

Aaron S. Kesselheim belinostat C. Joseph Ross Daval cancer David A. Russler-Germain Edward Cliff FDA Oncology Journal of Clinical Oncology OncoDaily Oncology Peter MacCallum Cancer Centre pralatrexate T-cell lymphoma The Royal Melbourne Hospital
Special Coverage
Blog
Nov 21, 2024, 06:44
Hedley Lewis: Gratitude to all The Cows who participated in the Virgin Active South Africa Ride Joburg
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024
Blog
Nov 20, 2024, 20:38
Franklin Iheanacho: Changing treatment patterns for hepatocellular carcinoma
Insight
Nov 20, 2024, 20:27
HIPEC improves overall survival in recurrent epithelial ovarian cancer
Blog
Nov 20, 2024, 19:12
Medicaid Cancer Foundation at 1Ummah Annual Convention
Insight
Nov 20, 2024, 19:12
Sahar Mansour: Advancing Breast Microcalcification Detection with AI
Blog
Nov 20, 2024, 19:12
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Blog
Nov 20, 2024, 19:12
Virtual tumor board on the management of a patient with Metastatic Squamous NSCLC - IASLC
Insight
Nov 20, 2024, 19:12
Nareg Varjabedian: Antidiabetic Drugs and Cancer Prevention
Insight
Nov 20, 2024, 19:12
Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer